Syngene International Ltd - 539268 - Intimation Of Resignation Letter Of Dr. Mahesh Bhalgat In Terms Of Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation of resignation letter of Dr, Mahesh Bhalgat under Regulation 30 of SEBI (LODR) Regulation, 2015 Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with Analyst/Institutional investor. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with Analyst/Institutional investor. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with Analyst/Institutional investor. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the link for the transcript of the Q3 FY2024 Earnings Call conducted on January 25, 2024 and uploaded on the Company's website. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Advertisement of newspaper - Financial Results
Syngene International Q3 FY24 Results Live: Profit Rises by 1.64% YoY
Syngene International Q3 FY24 Results Live: Revenue increased by 8.6% YoY & profit increased by 1.64% YoY Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find the link for the audio recording of the Q3 FY24 Earnings Call conducted on January 25, 2024 and uploaded on website of the Company on January 25, 2024. Syngene Q3 net profit up marginally
The company's revenue from operations improved 8.6 per cent to 853.5 crore Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation quarter and nine months ended December 31, 2023 financial results.